NASD · Healthcare · Health Information Services · USA
Tempus AI Inc is a large cap company (market value between $10 billion and $200 billion) in the Health Information Services industry.
Tempus AI is a healthcare technology company developing Intelligent Diagnostics by applying artificial intelligence to laboratory testing. The company operates the Tempus Platform, which integrates clinical and molecular data from healthcare institutions to personalize test results and guide treatment decisions. Its offerings include diagnostic services and data analytics applications for pharmaceutical companies and physicians.
From its FY2025 annual report (Form 10-K)
Intrinsic value, DCF valuation, financial health and value investing analysis for the Tempus AI Inc stock.
Overvalued: intrinsic value $10.71 per share, market price $64.34, margin of safety -500.8% (as of 2026-10-19).
A 1.8x revenue multiple, discounted for its losses, values the shares at $10.71; the price of $64.34 is 501% above that value.
17 more funds hold it; the full list is part of the paid plan.
All 41 Health Information Services stocks
13 more in this industry show a wider margin of safety.
TEM is overvalued (as of the 2026-10-19 close). A 1.8x revenue multiple, discounted for its losses, values the shares at $10.71; the price of $64.34 is 501% above that value.
$10.71 per share (as of the 2026-10-19 close), against a market price of $64.34. That is a margin of safety of -500.8%. The value is the average of the valuation methods that apply to this company, recomputed every night after the US close.